Minerva Neurosciences Inc (NASDAQ:NERV)
| 9.18 Delayed Data As of Sep 30 |  -0.37 / -3.87%Today’s Change | 2.51 Today|||52-Week Range 15.27 | +43.26% Year-to-Date |
Latest NERV News | Press Releases
No recent news for Minerva Neurosciences Inc.
Today’s Trading
| Previous close | 9.55 |
| Today’s open | 9.66 |
| Day’s range | 9.10 - 10.20 |
| Volume | 48,426 |
| Average volume (3 months) | 3,986,307 |
| Market cap | $50.2M |
Data as of 4:01pm ET, 09/30/2022
Growth & Valuation
| Earnings growth (last year) | -2,557.38% |
| Earnings growth (this year) | +45.21% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 6.29 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MBIOMustang Bio Inc | +0.01 | +1.84% |
| ONCTOncternal Therapeuti... | +0.04 | +4.34% |
| MEIPMEI Pharma Inc | -0.01 | -1.31% |
| PRQRProQR Therapeutics N... | -0.01 | -0.75% |
Data as of 4:01pm ET, 09/30/2022
Financials
| Next reporting date | November 7, 2022 |
| EPS forecast (this quarter) | -$1.38 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$49.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
